A Rare Manifestation of Secondary Hyperparathyroidism Due to Brown Tumors: A Case Report.

IF 0.7 Q3 MEDICINE, GENERAL & INTERNAL

International Medical Case Reports Journal Pub Date : 2024-02-26 eCollection Date: 2024-01-01 DOI:10.2147/IMCRJ.S437191

Maria Boudina, Eleana Zisimopoulou, Pantelitsa Rakitzi, Sotirios Barbanis, Eleni Syndouka, Chrysanthi Zouli, Aimilia Fotiadou, Mariana Stamati Stamati, Chrysanthi Balodimou, George Christantoniou, Alexandra Chrisoulidou

{"title":"A Rare Manifestation of Secondary Hyperparathyroidism Due to Brown Tumors: A Case Report.","authors":"Maria Boudina, Eleana Zisimopoulou, Pantelitsa Rakitzi, Sotirios Barbanis, Eleni Syndouka, Chrysanthi Zouli, Aimilia Fotiadou, Mariana Stamati Stamati, Chrysanthi Balodimou, George Christantoniou, Alexandra Chrisoulidou","doi":"10.2147/IMCRJ.S437191","DOIUrl":null,"url":null,"abstract":"Purpose: Brown tumors, also known as cystic fibrosa, are rare, benign, osteolytic, fibrotic lesions of the bones that occur secondary to hyperparathyroidism. They are caused by increased osteoclastic activity leading to an abnormal bone metabolism.Case description: Here, we present the case of a 58-year-old male, who presented with painful bony lesions, initially attributed to metastatic disease. After biochemical workout, imaging and biopsy, the nature of the lesions was revealed. We discuss the differential diagnosis and clinical management of the disease.Conclusion: Patients with brown tumors should be assessed in the differential diagnosis of bony lesions and should always be tested for hyperparathyroidism. An early diagnosis is crucial for the successful treatment of such patients.","PeriodicalId":14337,"journal":{"name":"International Medical Case Reports Journal","volume":null,"pages":null},"PeriodicalIF":0.7000,"publicationDate":"2024-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10907129/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Medical Case Reports Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2147/IMCRJ.S437191","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose: Brown tumors, also known as cystic fibrosa, are rare, benign, osteolytic, fibrotic lesions of the bones that occur secondary to hyperparathyroidism. They are caused by increased osteoclastic activity leading to an abnormal bone metabolism.

Case description: Here, we present the case of a 58-year-old male, who presented with painful bony lesions, initially attributed to metastatic disease. After biochemical workout, imaging and biopsy, the nature of the lesions was revealed. We discuss the differential diagnosis and clinical management of the disease.

Conclusion: Patients with brown tumors should be assessed in the differential diagnosis of bony lesions and should always be tested for hyperparathyroidism. An early diagnosis is crucial for the successful treatment of such patients.

查看原文本刊更多论文

棕色肿瘤导致的继发性甲状旁腺功能亢进症的罕见表现：病例报告

目的：棕色瘤又称囊性纤维瘤，是继发于甲状旁腺功能亢进症的罕见、良性、溶骨性、纤维性骨骼病变。它们是由破骨细胞活性增加导致骨代谢异常引起的：我们在此介绍了一名58岁男性的病例，他出现了疼痛的骨骼病变，最初被认为是转移性疾病所致。经过生化检查、影像学检查和活组织检查后，病变的性质被揭示出来。我们讨论了该病的鉴别诊断和临床治疗：结论：在鉴别诊断骨骼病变时，应评估棕色肿瘤患者，并应始终检测甲状旁腺功能是否亢进。早期诊断是成功治疗此类患者的关键。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

International Medical Case Reports Journal MEDICINE, GENERAL & INTERNAL-

CiteScore

1.40

自引率

0.00%

发文量

135

审稿时长

16 weeks

期刊介绍： International Medical Case Reports Journal is an international, peer-reviewed, open access, online journal publishing original case reports from all medical specialties. Submissions should not normally exceed 3,000 words or 4 published pages including figures, diagrams and references. As of 1st April 2019, the International Medical Case Reports Journal will no longer consider meta-analyses for publication.